Full prescribing information, including a boxed warning, is available at http://www.zyprexa.com.
Schizophrenia is a severe and debilitating psychosis often characterized by acute episodes of delusions (false beliefs that cannot be corrected by reason), hallucinations (usually in the form of non-existent voices) and long- term impairments such as diminished emotion, lack of interest and depressive signs and symptoms, such as hopelessness and suicidal thoughts.(1) It is usually associated with a disruption in social and family relationships. Schizophrenia is the most common severe mental illness. Twenty four million people suffer from schizophrenia worldwide. (2,3)
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.
Zyprexa(R) (olanzapine, Lilly)
(1) Weiden P, Scheifler P, Diamond R, et al. Breakthroughs in
Antipsychotic Medications. New York: W.W. Norton & Company, 1999.
|SOURCE Eli Lilly and Company|
Copyright©2007 PR Newswire.
All rights reserved